gluten

Allergenexperimental

Gluten is a structural protein complex naturally found in certain cereal grains. The term gluten usually refers to the elastic network of a wheat grain's proteins, gliadin and glutenin primarily, which forms readily with the addition of water and often kneading in the case of bread dough. The types of grains that contain gluten include all species of wheat, and barley, rye, and some cultivars of oat; moreover, cross hybrids of any of these cereal grains also contain gluten, e.g. triticale. Gluten makes up 75–85% of the total protein in bread wheat. — Wikipedia

Clinical trial activity

35 trials · 39 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
3
Phase 3
2
Phase 4
0

Earliest trial started Sep 1, 2006 (NCT01100099)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • GlutenImmunity, desensitized

    Gluten immunity, desensitized

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • gluten
  • gluten

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06900946N/AApr 1, 2025National Nutrition and Food Technology Institute
NCT05894746N/AMay 4, 2023The Ekhaga Foundation, Stockholm, Sweden, University of Gothenburg, University of Skövde
NCT05636293Phase 2Jan 1, 2023Harvard University, Pfizer
NCT05209568N/AOct 1, 2022Celiac Disease Foundation, Harvard University, University of Colorado
NCT04530123Phase 2Apr 29, 2021Takeda
NCT04604795Phase 1Nov 6, 2020GlaxoSmithKline
NCT04614571N/ANov 2, 2020Regeneron
NCT04054544Early Phase 1 (Phase 1)Oct 7, 2019Merck
NCT03664531N/ASep 30, 2018McMaster University
NCT03653689N/ASep 10, 2018Chalmers University of Technology, Uppsala University
NCT03714646N/ASep 5, 2018Maastricht University
NCT03409796Early Phase 1 (Phase 1)Apr 24, 2018Takeda
NCT03288831N/AOct 10, 2017Mayo Clinic
NCT03183609N/AJul 10, 2017University of Maryland
NCT03798249N/AMay 11, 2017Katholieke Universiteit Leuven
NCT02464150N/AApr 1, 2017Osaka University, South-Eastern Norway Regional Health Authority, Stiftelsen Helse og Rehabilitering, University of Oslo
NCT03798262N/AFeb 16, 2017Katholieke Universiteit Leuven
NCT02936297N/AJun 1, 2016Thomas Jefferson University
NCT03129906N/ASep 25, 2015Federal University of Minas Gerais
NCT01506349N/AJun 1, 2015Harvard University
Showing 20 of 35 trials
Page 1 / 2

Organizations

Research & Development (39)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Harvard UniversityAcademic/Hospital5522008
Aarhus UniversityAcademic/Hospital3312009
Katholieke Universiteit LeuvenAcademic/Hospital2212017
Nordic Centre of ExcellenceAcademic/Hospital2012009
Osaka UniversityAcademic/Hospital2222006
South-Eastern Norway Regional Health AuthorityGovernment2022006
TakedaFor profit2222018
The Danish Obesity Research CentreAcademic/Hospital2012009
University of CopenhagenAcademic/Hospital2112012
University of OsloAcademic/Hospital2022006
Celiac Disease FoundationAcademic/Hospital1012022
Chalmers University of TechnologyAcademic/Hospital1012018
Federal University of Minas GeraisAcademic/Hospital1112015
GlaxoSmithKlineFor profit1112020
Hospital Mutua de TerrassaAcademic/Hospital1112011
ImmusanT, Inc.For profit1012013
Joslin Diabetes CenterAcademic/Hospital1112013
Maastricht UniversityAcademic/Hospital1112018
Mayo ClinicAcademic/Hospital1112017
McMaster UniversityAcademic/Hospital1112018
39 organizations
Page 1 / 2